1. Home
  2. WEYS vs VNDA Comparison

WEYS vs VNDA Comparison

Compare WEYS & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weyco Group Inc.

WEYS

Weyco Group Inc.

HOLD

Current Price

$32.38

Market Cap

280.9M

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$8.74

Market Cap

474.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEYS
VNDA
Founded
1906
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
280.9M
474.0M
IPO Year
1995
2005

Fundamental Metrics

Financial Performance
Metric
WEYS
VNDA
Price
$32.38
$8.74
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$14.90
AVG Volume (30 Days)
12.6K
3.7M
Earning Date
06-08-2026
01-01-0001
Dividend Yield
3.24%
N/A
EPS Growth
N/A
N/A
EPS
1.50
N/A
Revenue
$290,290,000.00
$216,105,000.00
Revenue This Year
N/A
$21.50
Revenue Next Year
N/A
$38.67
P/E Ratio
$22.21
N/A
Revenue Growth
N/A
8.72
52 Week Low
$25.51
$3.81
52 Week High
$34.83
$9.91

Technical Indicators

Market Signals
Indicator
WEYS
VNDA
Relative Strength Index (RSI) 53.96 56.69
Support Level $30.61 $7.39
Resistance Level $33.93 $9.35
Average True Range (ATR) 1.35 0.57
MACD 0.15 0.13
Stochastic Oscillator 61.65 49.81

Price Performance

Historical Comparison
WEYS
VNDA

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: